Rankings
▼
Calendar
IRD FY 2024 Earnings — Opus Genetics, Inc. Revenue & Financial Results | Market Cap Arena
IRD
Opus Genetics, Inc.
$349M
FY 2024 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$11M
-42.3% YoY
Gross Profit
$11M
100.0% margin
Operating Income
-$62M
-564.7% margin
Net Income
-$58M
-523.4% margin
EPS (Diluted)
$-2.15
Cash Flow
Operating Cash Flow
-$26M
Free Cash Flow
-$26M
Stock-Based Comp.
$3M
Balance Sheet
Total Assets
$37M
Total Liabilities
$30M
Stockholders' Equity
$7M
Cash & Equivalents
$30M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$11M
$19M
-42.3%
Gross Profit
$11M
$19M
-42.3%
Operating Income
-$62M
-$11M
-487.7%
Net Income
-$58M
-$10M
-476.1%
← Q4 2023
All Quarters
Q1 2024 →